483 Zhejiang Kangle Pharmaceutical (Binhai Plant) Jul 2016

483 Zhejiang Kangle Pharmaceutical (Binhai Plant) Jul 2016

$119 - Not in Stock

FDA investigators audited the Zhejiang Kangle Pharmaceutical (Binhai Plant) - Wenzhou, China facility and issued inspectional observations (via FDA 483) on 22 Jul 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Jul 2016
  • Location: Wenzhou, China
  • FEI: 3010728912

Pre-Order Not Available